Biomarin Pharmaceutical will report earnings after the market closes. View Calendar The market is expecting a ±9.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.7%. View Expected Move (Conf Call: May 4 4:30 PM)
Biomarin Pharmaceutical has traded lower yet again today, last trading at 54.75. Since this spiral started on 11-Mar-2026, the stock has dropped -10.1% in total. This is the longest downward trend in the last year for BMRN. View Stock Chart
